| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/22/2006 | EP1636248A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 03/22/2006 | EP1307578B1 Ascorbic acid production from yeasts |
| 03/22/2006 | EP1246909B1 Method for the production of hydroxynitrile lyases |
| 03/22/2006 | EP1129191B1 Methods of diagnosing or treating neurological diseases |
| 03/22/2006 | EP1095147B1 Polyketides, their preparation, and materials for use therein |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0832239B1 Camp factor of streptococcus uberis |
| 03/22/2006 | CN1751124A Microbial production of CoQ10 |
| 03/22/2006 | CN1751121A Novel vector |
| 03/22/2006 | CN1751120A Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways |
| 03/22/2006 | CN1749399A Pichia yeast phytase expression system containing reorganized ethyl alcohol oxidase promotor |
| 03/22/2006 | CN1749390A Method for producing L-amino acids by fermentation using bacteria having enhanced expression of xylose utilization genes |
| 03/22/2006 | CN1246470C Process for preparing L-amino acids using strains of enterobacteriaceae family which contain an attenuated aspA gene |
| 03/22/2006 | CN1246468C Fermentation process for the preparation of L-amino acids using strains of the family enterobacteriaceae |
| 03/22/2006 | CN1246466C Microbe process for preparing (4R, 6R)-4-hydroxyl-2,2,6-trimethyl cyclohexanone |
| 03/22/2006 | CN1246460C Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase |
| 03/22/2006 | CN1246458C Human cervical cancer 2 protooncogene and protein encoded therein |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246455C Alpha amylase mutants |
| 03/22/2006 | CN1246453C Recombinant hygrophilous aeromonad producing copolymer PHBHHx and its construction and application |
| 03/22/2006 | CN1246452C Recombined strain for producing polyhydroxy fatty acid ester and its construction and use |
| 03/22/2006 | CN1246451C Application of cloud point system in biotransformation |
| 03/22/2006 | CN1246450C Process for producing chitosan enzyme producing fungus and low poly chitosan |
| 03/22/2006 | CN1246449C Method for promoting and inducing generation and accumulation of ganoderma lucidum secondary metabolite |
| 03/22/2006 | CN1246333C Receptor in the EDb Fibronection domain |
| 03/22/2006 | CN1246260C Process for producing organic biological composite fertilizer from biological waste material |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245957C Method for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 03/22/2006 | CN1245894C Cultured protein hydrolytic product |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance |
| 03/21/2006 | US7015036 Human liver cell line |
| 03/21/2006 | US7015027 An attenuated, tumour-targeting bacterium comprising a mammalian sodium symporter (NIS) gene encoding a protein that promotes accumulation of a radionuclide within the bacterium |
| 03/21/2006 | US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders |
| 03/21/2006 | US7015014 Isolation of carotenoid crystals |
| 03/21/2006 | US7015010 Method for producing L-glutamic acid by fermentation accompanied by precipitation |
| 03/21/2006 | US7015008 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 03/21/2006 | US7015001 Comprises nucleotide sequences coding spinosyn-A biosynthetic enzyme for preparing pesticides; biological pest control agents |
| 03/21/2006 | US7014993 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein |
| 03/21/2006 | US7014857 Anti-sepsis conjugate vaccine |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | US7014595 Ice skating training apparatus for playing hockey |
| 03/21/2006 | CA2146063C Use of alkaline proteases in industrial textile washing processes |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/16/2006 | WO2006028684A2 Phytases, nucleic acids encoding them and methods of making and using them |
| 03/16/2006 | WO2006028428A1 Antimicrobial aerococus viridans strain n°167k and a drug viabak based thereon |
| 03/16/2006 | WO2006028164A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | WO2006028063A1 Dna fragment having promoter function |
| 03/16/2006 | WO2006028048A1 Method of fungus culturing |
| 03/16/2006 | WO2006027561A1 Production and use of surface active agents |
| 03/16/2006 | WO2006027265A1 Means and methods for preventing and/or treating caries |
| 03/16/2006 | WO2006026992A1 Altered structure of n-glycans in a fungus |
| 03/16/2006 | WO2005118874A9 Enhancing protein expression |
| 03/16/2006 | WO2005111195A3 Improved prebiotic |
| 03/16/2006 | WO2005007818A8 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 03/16/2006 | WO2004000220A3 Methods for purifying viral particles for gene therapy |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060057723 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/16/2006 | US20060057704 Composition |
| 03/16/2006 | US20060057703 Method for the evaluation of implantable materials |
| 03/16/2006 | US20060057702 comprises an Fc region having impaired effector function; treating a disease characterized by aberrant deposition of a protein in the brain of a subject; Alzheimer's disease, Down's syndrome, cerebral amyloid angiopathy |
| 03/16/2006 | US20060057701 Antibodies directed against amyloid-beta peptide and methods using same |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057699 Vaccines; mammalian nucleated cells and mammalian adherent cells that are stably infected with an Anaplasma species |
| 03/16/2006 | US20060057698 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 03/16/2006 | US20060057697 Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue |
| 03/16/2006 | US20060057696 Sugar chain synthases |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057690 Glycerol-3-phosphate o-acyltransferase promoter for gene expression in oleaginous yeast |
| 03/16/2006 | US20060057686 L-glutamic acid-producing microorganism and a method for producing L-glutamic acid |
| 03/16/2006 | US20060057685 Method for producing abnormal amino acids using a bacterium of the Enterobacteriaceae family having all acetohydroxy acid synthases inactivated |
| 03/16/2006 | US20060057676 which are induced by fermentable glucose or non-fermentable ethanol |
| 03/16/2006 | US20060057675 Human toll homologue |
| 03/16/2006 | US20060057674 Translocating enzyme as a selection marker |
| 03/16/2006 | US20060057672 Exo-endo cellulase fusion protein |
| 03/16/2006 | US20060057666 Human g protein coupled receptor |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057607 Small RNAs and bacterial strains involved in quorum sensing |
| 03/16/2006 | US20060057589 Identification and detection of algae species, strains and toxins |
| 03/16/2006 | US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/16/2006 | US20060057164 Isolated, purified polynucleotides, expression vector, host cells, antibodies; mutation functionally disrupting catalytic domain |
| 03/16/2006 | US20060057160 Vaccine composition |
| 03/16/2006 | US20060057155 Adp-ribosylating bacterial toxins |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057112 Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof |
| 03/16/2006 | DE19943383B4 Regulatorische Sequenzen und Expressionskassetten für Hefen Regulatory sequences and expression cassettes for yeasts |
| 03/16/2006 | CA2579709A1 Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink |
| 03/16/2006 | CA2579154A1 Method of culturing a microorganism |
| 03/16/2006 | CA2578988A1 Phytases, nucleic acids encoding them and methods of making and using them |
| 03/16/2006 | CA2572178A1 Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture |
| 03/15/2006 | EP1634954A1 Protease, dna coding for the protease and process for producing the protease |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |